The European Patent Office declared a contested mRNA patent owned by Moderna (MRNA.O) invalid on Tuesday, the office said, handing a win to BioNTech (22UAy.DE) and its partner Pfizer (PFE.N) in a patent dispute between the two coronavirus vaccine makers.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,